logo-loader
NASDAQ:AUTL

Autolus Ltd

Receive alerts
Market:
NASDAQ
Market Cap:
$539.56 m
Price
10.33 USD
Change
1.18%
52 weeks high
32.80
52 weeks low
9.40

In brief

Focused on the development of precisely targeted, controlled and highly active T cell therapies that are designed to offer cancer patients substantial benefits over existing standard of care.
Autolus is a leader in T cell programming technologies and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting both hematological cancers and solid tumors.